Leonardo Boiocchi
Leonardo Boiocchi
Medical Resident, Pathology Department, Massachusetts General Hospital; Clinical Fellow, Harvard
Verified email at partners.org
Cited by
Cited by
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis
C Vener, NS Fracchiolla, U Gianelli, R Calori, F Radaelli, A Iurlo, ...
Blood, The Journal of the American Society of Hematology 111 (4), 1862-1865, 2008
Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up
W Ghanima, JT Geyer, CS Lee, L Boiocchi, AA Imahiyerobo, A Orazi, ...
Haematologica 99 (5), 937-944, 2014
The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas
M Locatelli, S Ferrero, FM Boneschi, L Boiocchi, M Zavanone, SM Gaini, ...
Journal of neuroimmunology 260 (1-2), 99-106, 2013
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease
L Boiocchi, R Espinal-Witter, JT Geyer, J Steinhilber, I Bonzheim, ...
Modern Pathology 26 (2), 204-212, 2013
BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells
L Boiocchi, S Lonardi, W Vermi, S Fisogni, F Facchetti
Blood, The Journal of the American Society of Hematology 122 (2), 296-297, 2013
Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromalá…
L Boiocchi, A Orazi, W Ghanima, M Arabadjief, JB Bussel, JT Geyer
Modern Pathology 25 (1), 65-74, 2012
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents
W Ghanima, P Junker, HC Hasselbalch, L Boiocchi, JT Geyer, X Feng, ...
British journal of haematology 155 (2), 248-255, 2011
Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage
L Boiocchi, S Mathew, U Gianelli, A Iurlo, T Radice, S Barouk-Fox, ...
Modern pathology 26 (12), 1577-1585, 2013
Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms
L Boiocchi, C Vener, F Savi, E Bonoldi, A Moro, NS Fracchiolla, A Iurlo, ...
Journal of clinical pathology 64 (3), 226-231, 2011
Human glioma tumors express high levels of the chemokine receptor CX3CR1
M Locatelli, L Boiocchi, S Ferrero, FM Boneschi, M Zavanone, S Pesce, ...
European cytokine network 21 (1), 27-33, 2010
Prostatic stromal tumor with fatal outcome in a young man: histopathological and immunohistochemical case presentation
P Colombo, GL Ceresoli, L Boiocchi, G Taverna, F Grizzi, A Bertuzzi, ...
Rare tumors 2 (4), rt. 2010. e57, 2010
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia
B Federmann, M Abele, DSR Cuesta, W Vogel, L Boiocchi, L Kanz, ...
Human pathology 45 (12), 2471-2479, 2014
Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases
L Boiocchi, RE Witter, B He, S Subramaniyam, S Mathew, K Nie, A Cerutti, ...
American journal of clinical pathology 137 (4), 647-659, 2012
Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications
L Boiocchi, U Gianelli, A Iurlo, F Fend, I Bonzheim, D Cattaneo, ...
Modern Pathology 28 (11), 1448-1457, 2015
High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes
U Gianelli, NS Fracchiolla, P Bucciarelli, V Ferla, L Boiocchi, F Savi, ...
American journal of clinical pathology 139 (3), 380-387, 2013
Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms
L Boiocchi, RP Hasserjian, O Pozdnyakova, WJ Wong, JK Lennerz, LP Le, ...
Human pathology 86, 1-11, 2019
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib
A Iurlo, D Cattaneo, L Boiocchi, N Orofino, E Fermo, A Cortelezzi, ...
Annals of hematology 94 (10), 1749-1751, 2015
The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations
U Gianelli, D Cattaneo, A Bossi, I Cortinovis, L Boiocchi, YC Liu, ...
Modern Pathology 30 (2), 169, 2017
A giant adrenal myelolipoma in a beta‐thalassemia major patient: Does ineffective erythropoiesis play a role?
I Motta, L Boiocchi, P Delbini, M Migone De Amicis, E Cassinerio, ...
American journal of hematology 91 (12), 1281-1282, 2016
Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia
N Fusco, A Bonometti, C Augello, S Fabris, L Boiocchi, S Fiori, D Morotti, ...
Histopathology 70 (6), 1000-1008, 2017
The system can't perform the operation now. Try again later.
Articles 1–20